Rankings
▼
Calendar
FOLD Q4 2016 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FOLD
Amicus Therapeutics, Inc.
$5B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
Gross Profit
$2M
82.7% margin
Operating Income
-$45M
-1603.9% margin
Net Income
-$59M
-2071.6% margin
EPS (Diluted)
$-0.44
QoQ Revenue Growth
+33.1%
Cash Flow
Operating Cash Flow
-$32M
Free Cash Flow
-$32M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$1.0B
Total Liabilities
$677M
Stockholders' Equity
$360M
Cash & Equivalents
$187M
← FY 2016
All Quarters
Q1 2017 →